Furthermore, pathogenic variants in other high- and moderate-risk genes, such as TP53, CHEK2, ATM, STK11, and PALB2, also lead to increased BC risk, indicating high complexity in BC predisposition [14]. Here, CHEK2 is linked to breast cancer.